OncoMed Presents New Data in Six Anti-Cancer Stem Cell Programs at AACR
| Autor: | OncoMed Pharmaceuticals, Inc. |
|---|---|
| Zdroj: | Business Wire (English). 04/09/2013. |
| Abstrakt: | OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today summarized new data highlighting the progress of OncoMed’s pipeline of anti-cancer biologics presented this week in an oral presentation and five posters at the Annual Meeting of the American Association of Cancer Research in Washington, DC. [ABSTRACT FROM PUBLISHER] |
| Databáze: | Regional Business News |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |